Slate Medicines | $130,000,000 | (Feb 25, 2026)
Letter AI | $40,000,000 | (Feb 25, 2026)
Subject | $28,000,000 | (Feb 25, 2026)
Certified by Founder
Lodge
Respondent
investor
- 11/11/2022
- Seed
- $2,300,000
Respondent is a marketplace for sourcing business professionals for in-depth research interviews.
IBM, Oracle, Atlassian, Twilio, Microsoft, and many more choose to leverage Respondent for their research interviews and to make smarter business decisions.
Reach out to: contact@respondent.io
- Industry Research Services
- Website https://www.respondent.io/
- LinkedIn https://www.linkedin.com/company/respondent.io/
Related People
Jack P.Founder
Australia -
Sydney, New South Wales
Respondent is building a new category marketplace that connects researchers with high-quality research participants. By reducing research timelines from 4-6 weeks to days and shrinking costs by 90%+, we make business-changing insights available to researchers of all types -- from in-house research teams at Airbnb and Microsoft to startup founders hunting for product-market fit.
Centauri Therapeutics Limited | $8,107,170 | (Feb 25, 2026)
Slang AI | $36,000,000 | (Feb 25, 2026)
Brilliant Harvest Inc. | $4,000,000 | (Feb 25, 2026)
Koah | $20,500,000 | (Feb 25, 2026)
Nimble | $47,000,000 | (Feb 25, 2026)
General Magic | $7,200,000 | (Feb 25, 2026)
Circadian Risk Inc. | $6,000,000 | (Feb 25, 2026)
Neural Earth | $9,300,000 | (Feb 25, 2026)
Jampack AI | $3,200,000 | (Feb 25, 2026)